Your browser doesn't support javascript.
loading
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Palazón-Carrión, Natalia; Martín García-Sancho, Alejandro; Nogales-Fernández, Esteban; Jiménez-Cortegana, Carlos; Carnicero-González, Fernando; Ríos-Herranz, Eduardo; de la Cruz-Vicente, Fátima; Rodríguez-García, Guillermo; Fernández-Álvarez, Rubén; Martínez-Banaclocha, Natividad; Gumà-Padrò, Josep; Gómez-Codina, José; Salar-Silvestre, Antonio; Rodríguez-Abreu, Delvys; Gálvez-Carvajal, Laura; Labrador, Jorge; Guirado-Risueño, María; García-Domínguez, Daniel J; Hontecillas-Prieto, Lourdes; Espejo-García, Pablo; Fernández-Román, Isabel; Provencio-Pulla, Mariano; Sánchez-Beato, Margarita; Navarro, Marta; Marylene, Lejeune; Álvaro-Naranjo, Tomás; Casanova-Espinosa, Maria; Sánchez-Margalet, Victor; Rueda-Domínguez, Antonio; de la Cruz-Merino, Luis.
Affiliation
  • Palazón-Carrión N; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.
  • Martín García-Sancho A; Department of Medicine, University of Seville, Seville, Spain.
  • Nogales-Fernández E; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Jiménez-Cortegana C; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.
  • Carnicero-González F; Department of Medicine, University of Seville, Seville, Spain.
  • Ríos-Herranz E; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Hospital Universitario Virgen Macarena, Seville, Spain.
  • de la Cruz-Vicente F; Department of Hematology, Hospital San Pedro de Alcántara de Cáceres, Cáceres, Spain.
  • Rodríguez-García G; Department of Hematology, Hospital Universitario de Valme, Seville, Spain.
  • Fernández-Álvarez R; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Martínez-Banaclocha N; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Gumà-Padrò J; Department of Hematology, Cabueñes Hospital, Gijón, Spain.
  • Gómez-Codina J; Department of Clinical Oncology, Hospital General Universitario de Alicante, Alicante, Spain.
  • Salar-Silvestre A; Department of Clinical Oncology, Hospital Universitari Sant Joan de Reus URV, IISPV, Reus, Spain.
  • Rodríguez-Abreu D; Department of Clinical Oncology, Hospital Universitario La Fé, Valencia, Spain.
  • Gálvez-Carvajal L; Department of Hematology, Hospital del Mar, Barcelona, Spain.
  • Labrador J; Department of Clinical Oncology, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain.
  • Guirado-Risueño M; Department of Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • García-Domínguez DJ; Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
  • Hontecillas-Prieto L; Department of Clinical Oncology, Hospital General Universitario de Elche, Elche, Spain.
  • Espejo-García P; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.
  • Fernández-Román I; Department of Medicine, University of Seville, Seville, Spain.
  • Provencio-Pulla M; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Sánchez-Beato M; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.
  • Navarro M; Department of Medicine, University of Seville, Seville, Spain.
  • Marylene L; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Álvaro-Naranjo T; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.
  • Casanova-Espinosa M; Department of Medicine, University of Seville, Seville, Spain.
  • Sánchez-Margalet V; Department of Hematology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Rueda-Domínguez A; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain.
  • de la Cruz-Merino L; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, CIBERONC, Madrid, Spain.
Clin Cancer Res ; 28(17): 3658-3668, 2022 09 01.
Article in En | MEDLINE | ID: mdl-35727601
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Spain